Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
Are there press releases or SEC/State filings naming Neurocept founders in 2014 2015?
Executive Summary
The available documents in the provided dataset do not contain a clear press release or SEC/State filing that names Neurocept founders in 2014 or 2015. Instead, the material references multiple similarly named neuro-focused companies and filings—Applied NeuroSolutions, NeuroSigma, Neurona, Neurotrope, and NeuroCeption—creating a plausible conflation that explains why a direct match for “Neurocept founders” does not appear in 2014–2015 records reviewed here [1] [2] [3] [4] [5] [6] [7] [8].
1. Why the record comes up empty — corporate names that look alike and reporting gaps
The strongest theme across the documents is name confusion and reporting irregularities rather than a direct identification of Neurocept’s founders. The SEC’s 2014 administrative decision discusses revocations and delinquencies for Applied NeuroSolutions, indicating failure to file timely periodic reports, but it does not name Neurocept or its founders [1]. Separate 2014–2015 filings discuss NeuroSigma, Neurona, and Neurotrope in contexts that list executives and officers—NeuroSigma names Leon Ekchian as president and CEO in a Form S‑1/A; a 2014 Form D for Neurona lists several executives; and a 2015 Neurotrope filing documents company activities—yet none of these filings explicitly identify “Neurocept founders” [2] [3] [7]. These documents show active corporate disclosure among neurotech firms in that period but no direct evidence for the claim.
2. Signals that could be misread as support — market reports and prize announcements
Some materials in the dataset could be misconstrued as corroboration even though they do not name founders. The Neuro Startup Challenge and market research in 2014–2015 document increased activity and new teams in neurotech, which could lead observers to infer startup formation and founder publicity in that window; those sources do not, however, list Neurocept founders or official filings naming them [4] [6]. Another source is promotional material for a company called NeuroCeption from 2020, which discusses product features but is temporally and corporately distinct from the 2014–2015 SEC/state filing record, and so offers no direct verification [5]. The pattern is one of contextual activity in the sector rather than documentary proof.
3. Alternative explanations — corporate renaming, subsidiary movement, and identity drift
A plausible explanation for the absence of clear 2014–2015 naming is entity identity drift: founders may have been named under a different corporate banner (Applied NeuroSolutions, NeuroSigma, Neurona, Neurotrope) or the company may have used a different operational name in filings. The dataset contains filings for several similarly named companies and indicates that at least one (Applied NeuroSolutions) had compliance problems in 2014, which can muddy public records and hide linkage between founders and a later-branded company [1]. Given these documents, it is reasonable to infer that any claim asserting press releases or SEC/State filings naming Neurocept founders in 2014–2015 is unsupported by the records provided here.
4. What the documents do confirm — active neurotech filings, but not the specific claim
The assembled sources confirm robust filing activity by multiple neurotech entities during 2014–2015: an SEC administrative order addressing revocations, Form S‑1/A and Form D records listing executives and officers, and market reports and prize programs highlighting new teams entering the field. These records demonstrate that neuro-focused companies were disclosing executive names and pursuing capital or public filings, yet none of these entries in the dataset name Neurocept founders directly [1] [2] [3] [7]. That pattern is decisive: the dataset contains relevant contemporaneous filings, but they point to other entities, not to a clear Neurocept founders listing.
5. Where to look next and how to avoid conflation when verifying founders
To resolve the question definitively, search for contemporaneous press releases, SEC Forms (S‑1, D, 8‑K), and state incorporation/registration records that include the exact corporate name “Neurocept” and cross-reference DBA/previous names and officer lists; examine state-level incorporations and secretary-of-state filings for name changes or mergers that could show founders listed under a different entity. The documents provided here establish a credible reason for confusion—multiple similar names and at least one compliance lapse—but they do not substantiate the claim; therefore, further targeted records requests and searches of 2014–2015 press release archives and state registries are required to produce a definitive citation linking founder names to Neurocept [1] [2] [3] [4] [5] [6] [7] [8].